Financials

Discussions Technicals Seasonals

7762 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to PET PHARM BIOTECH CO LTD operating, investing, and financing activities

7762 free cash flow for H1 24 is -162.55 M TWD. For 2023, 7762 free cash flow was 8.08 M TWD and operating cash flow was 20.75 M TWD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—